|
Welcome to The Scientist's special supplement on schizophrenia. Scroll down for the table of contents. Please download the flash player to view this content
|
The human and financial toll of a terrible affliction
Hallucinations are just the beginning: Negative symptoms, lowered expectations make for a tough day-to-day struggle.
He shows it�s possible to survive, and thrive, with schizophrenia.
A nurse who cares for the whole person � body, and spirit.
Flaws in the system add to the tens of billions spent on schizophrenia every year, but advocates say there�s little will to invest in fixing it.
Why we need much more research into early onset
psychosis.
 What causes schizophrenia?
Scientists don�t agree on what neurotransmitters
� if any � are responsible for schizophrenia, but they agree on one thing: Its causes are complex.
In GABA, David Lewis finds shared transcription
products among people with schizophrenia.
How brain imaging is shaping our grasp of the
disorder.
Martha Shenton is pushing imaging boundaries in order to understand the schizophrenic brain.
A perspective on genes and the environment
in schizophrenia.
 What helps people with schizophrenia, from medication to clubhouses
Antipsychotics are effective, but carry significant
side effects and cost. What�s on the horizon?
A new class of antipsychotics aims at NMDA receptors.
The landmark study found that older
antipsychotics were just as effective as newer ones. Is anyone listening?
People with schizophrenia need support systems,
not just medications, to get well and stay healthy.
|
